Medtronic

Company

Investment-firm

Last deal

$3.2B
Local Amount - EUR 3B

Amount

Post-IPO Debt

Stage

29.05.2024

Date

9

all rounds

$9.1B

Total amount

General

About Company
Medtronic develops healthcare technology for chronic disease treatment.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Tyco Healthcare, Medina Medical, Inc.

founded date

01.01.1949

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Debt

IPO status

Private

Description

Medtronic is a global healthcare technology leader headquartered in Minneapolis, Minnesota. The company focuses on developing and manufacturing devices and therapies for over 30 chronic diseases, including heart failure, Parkinson's disease, obesity, and diabetes. Medtronic's four main business units are the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group. With a commitment to improving lives, Medtronic provides lifelong solutions for people with chronic pain and boldly tackles the most challenging health problems through innovative medical technologies, services, and solutions.
Contacts